- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04415723
A Supportive Care Programme for People With Heart Failure (SupportHeart)
Efficient health care systems for the management of chronic diseases in the community may improve clinical outcomes and simultaneously encourage patients to remain healthy. Supportive care, may contribute to empower heart failure (HF) patients for self- management and providing them with the follow-up and care based on their needs and values through the HF trajectory. To develop the current program an assessment of the support needs of HF patients' will be undertaken and the investigators will take into consideration of their personal preferences, for instance means of communication and way of exercise as part of the intervention. The present study aspires to evaluate the effectiveness of an individualized supportive care management program in terms of the four different components that comprise supportive care in HF. The objectives of this study are to:
- Determine supportive care needs of HF patients as reported in the literature.
- Explore Cypriot patients' identified supportive care needs.
- To develop and test a self-management supportive care programme for HF patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Limassol, Cyprus, 3036
- Recruiting
- Cyprus University of Technology; Nursing Department
-
Contact:
- Ekaterini Lambrinou, PhD,MSc,BSc
- Phone Number: +35799255576
- Email: ekaterini.lambrinou@cut.ac.cy
-
Contact:
- Martha Kyriakou, MSc,BSc
- Phone Number: +35799636583
- Email: martha_kyriakou@hotmail.com
-
Sub-Investigator:
- Martha Kyriakou, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- clinical diagnoses with HF (HFpEF or HFrEF), established by a cardiologist
- New York Heart Association classification stages I-IV
- Diagnosis established for at least 6 months before the start of the intervention period
- Ability to understand, write and read in Greek language
Exclusion Criteria:
- Refuse to take part in the research
- Dementia or other severe mental illness
- Transfer to nursing homes after discharge
- Difficulty in contacting them by a phone call
- Patients with chronic degenerative diseases (Alzheimer, cancer, etc)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
supportive care management programme
|
nurse-led management programme
|
|
No Intervention: control group
receive the usual care provided by the health care system of Cyprus
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Time Frame: Baseline
|
Quantitative data.
MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
|
Baseline
|
|
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Time Frame: 1st month
|
quantitative data The items of the questionnaire examines 3 dimentions.
The dimension scores were calculated as the sum of the items that represent each dimension.
Higher scores indicate worse quality of life.
|
1st month
|
|
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Time Frame: 3rd month
|
Quantitative data.
MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
|
3rd month
|
|
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Time Frame: 6th month
|
Quantitative data.
MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
|
6th month
|
|
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Time Frame: one year
|
Quantitative data.
MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
|
one year
|
|
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
Time Frame: Baseline
|
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
|
Baseline
|
|
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
Time Frame: 1st month
|
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
|
1st month
|
|
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
Time Frame: 3rd month
|
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
|
3rd month
|
|
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
Time Frame: 6th month
|
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
|
6th month
|
|
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
Time Frame: one year
|
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
|
one year
|
|
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Time Frame: Baseline
|
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson [ 1. Family/Significant others , 2. Friends] .
Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
|
Baseline
|
|
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Time Frame: 1st month
|
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson [ 1. Family/Significant others , 2. Friends] .
Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
|
1st month
|
|
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Time Frame: 3rd month
|
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson [ 1. Family/Significant others , 2. Friends] .
Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
|
3rd month
|
|
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Time Frame: 6th month
|
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson [ 1. Family/Significant others , 2. Friends] .
Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
|
6th month
|
|
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Time Frame: one year
|
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson [ 1. Family/Significant others , 2. Friends] .
Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
|
one year
|
|
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Time Frame: Baseline
|
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3).
It is designed to measure anxiety and depression (7 items for each subscale).
The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).
Higher scores indicate worse quality of life.
|
Baseline
|
|
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Time Frame: 1st month
|
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3).
It is designed to measure anxiety and depression (7 items for each subscale).
The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).
Higher scores indicate worse quality of life.
|
1st month
|
|
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Time Frame: 3rd month
|
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3).
It is designed to measure anxiety and depression (7 items for each subscale).
The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).
Higher scores indicate worse quality of life.
|
3rd month
|
|
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Time Frame: 6th month
|
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3).
It is designed to measure anxiety and depression (7 items for each subscale).
The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).
Higher scores indicate worse quality of life.
|
6th month
|
|
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Time Frame: one year
|
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3).
It is designed to measure anxiety and depression (7 items for each subscale).
The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).
Higher scores indicate worse quality of life.
|
one year
|
|
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
Time Frame: Baseline
|
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
|
Baseline
|
|
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
Time Frame: 1st month
|
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
|
1st month
|
|
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
Time Frame: 3rd month
|
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
|
3rd month
|
|
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
Time Frame: 6th month
|
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
|
6th month
|
|
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
Time Frame: one year
|
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self -Care of Heart Failure Index (Greek Version) SCHFI -Gr
Time Frame: Baseline
|
Quantitative data The SCHFI -Gr consists of 22 items representing 3 dimensions.
The dimension scores were calculated as the sum of the items that represent each dimension.
The negative item 8 was reversed coded before the calculation.
Increased scores indicates higher self care management.
|
Baseline
|
|
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
Time Frame: 1st month
|
Quantitative data The SCHFI -Gr consists of 22 items representing 3 dimensions.
The dimension scores were calculated as the sum of the items that represent each dimension.
The negative item 8 was reversed coded before the calculation.
Increased scores indicates higher self care management.
|
1st month
|
|
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
Time Frame: 3rd month
|
Quantitative data The SCHFI -Gr consists of 22 items representing 3 dimensions.
The dimension scores were calculated as the sum of the items that represent each dimension.
The negative item 8 was reversed coded before the calculation.
Increased scores indicates higher self care management.
|
3rd month
|
|
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
Time Frame: 6th month
|
Quantitative data The SCHFI -Gr consists of 22 items representing 3 dimensions.
The dimension scores were calculated as the sum of the items that represent each dimension.
The negative item 8 was reversed coded before the calculation.
Increased scores indicates higher self care management.
|
6th month
|
|
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
Time Frame: one year
|
Quantitative data The SCHFI -Gr consists of 22 items representing 3 dimensions.
The dimension scores were calculated as the sum of the items that represent each dimension.
The negative item 8 was reversed coded before the calculation.
Increased scores indicates higher self care management.
|
one year
|
|
Number of acute events and deterioration Despite advances in treatment, the prognosis of HF remains poor, accounting for 10% mortality rate after an acute event and 20-25% of patients will be readmitted within the first month after discharge.
Time Frame: Baseline
|
quantitative data in numerical scale
|
Baseline
|
|
Number of acute events and deterioration Despite advances in treatment, the prognosis of HF remains poor, accounting for 10% mortality rate after an acute event and 20-25% of patients will be readmitted within the first month after discharge.
Time Frame: 1st month
|
quantitative data in numerical scale
|
1st month
|
|
Number of acute events and deterioration Despite advances in treatment, the prognosis of HF remains poor, accounting for 10% mortality rate after an acute event and 20-25% of patients will be readmitted within the first month after discharge.
Time Frame: 3rd month
|
quantitative data in numerical scale
|
3rd month
|
|
Number of acute events and deterioration Despite advances in treatment, the prognosis of HF remains poor, accounting for 10% mortality rate after an acute event and 20-25% of patients will be readmitted within the first month after discharge.
Time Frame: 6th month
|
quantitative data in numerical scale
|
6th month
|
|
Number of acute events and deterioration Despite advances in treatment, the prognosis of HF remains poor, accounting for 10% mortality rate after an acute event and 20-25% of patients will be readmitted within the first month after discharge.
Time Frame: one year
|
quantitative data in numerical scale
|
one year
|
|
European Heart Failure Self-Care Behavior Scale - Gr9(Greek version) Grg-EHFScB
Time Frame: Baseline
|
Quantitative data.
EHFScBS-Gr9 is a 5-point Likert scale, from 1 to 5.The total score is calculated by summing the ratings for each item.
The total score ranges from 0 to 45 with higher scores indicating poorer self-care behaviors.
For the purposes of this program all items will be reversed coded so as higher score is associated with a higher level of self care management
|
Baseline
|
|
European Heart Failure Self-Care Behavior Scale- Gr9 (Greek version) Grg-EHFScB
Time Frame: 1st month
|
Quantitative data.
EHFScBS-Gr9 is a 5-point Likert scale, from 1 to 5.The total score is calculated by summing the ratings for each item.
The total score ranges from 0 to 45 with higher scores indicating poorer self-care behaviors.
For the purposes of this program all items will be reversed coded so as higher score is associated with a higher level of self care management
|
1st month
|
|
European Heart Failure Self-Care Behavior Scale - Gr9 (Greek version) Grg-EHFScB
Time Frame: 3rd month
|
Quantitative data.
EHFScBS-Gr9 is a 5-point Likert scale, from 1 to 5.The total score is calculated by summing the ratings for each item.
The total score ranges from 0 to 45 with higher scores indicating poorer self-care behaviors.
For the purposes of this program all items will be reversed coded so as higher score is associated with a higher level of self care management
|
3rd month
|
|
European Heart Failure Self-Care Behavior Scale- Gr9 (Greek version) Grg-EHFScB
Time Frame: 6th month
|
Quantitative data.
EHFScBS-Gr9 is a 5-point Likert scale, from 1 to 5.The total score is calculated by summing the ratings for each item.
The total score ranges from 0 to 45 with higher scores indicating poorer self-care behaviors.
For the purposes of this program all items will be reversed coded so as higher score is associated with a higher level of self care management
|
6th month
|
|
European Heart Failure Self-Care Behavior Scale - Gr9(Greek version) Grg-EHFScB
Time Frame: one year
|
Quantitative data.
EHFScBS-Gr9 is a 5-point Likert scale, from 1 to 5.The total score is calculated by summing the ratings for each item.
The total score ranges from 0 to 45 with higher scores indicating poorer self-care behaviors.
For the purposes of this program all items will be reversed coded so as higher score is associated with a higher level of self care management
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ekaterini Lambrinou, PhD,MSc,BSc, Cyprus University of Technology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0402/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on supportive care management programme
-
Ilknur YaziciogluCompletedColorectal Cancer | Colorectal (Colon or Rectal) CancerTurkey (Türkiye)
-
Izmir Bakircay UniversityCompletedNurse-led Supportive CareTurkey
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedOvarian Carcinoma | Malignant Uterine Neoplasm | Malignant Female Reproductive System Neoplasm | Ovarian Neoplasm | Uterine Neoplasm | Female Reproductive System Neoplasm | Suspicious for MalignancyUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
University of MichiganCompletedUterine Cervical Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Vulvar Neoplasms | Vaginal Neoplasms | Gynecologic NeoplasmsUnited States
-
Stanford UniversityCompletedAcute Myeloid Leukemia | Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Progressive Disease | Myelodysplastic Syndrome | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Fuzhou General HospitalRecruitingInfections | COVID-19 | Morality | Death, AssistedChina
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedCervical Carcinoma | Vaginal Carcinoma | Ovarian Carcinoma | Uterine Corpus Cancer | Vulvar CarcinomaUnited States